• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

HYPERGLUCOSE CIRCUMSTANCE RETARDED EGF-RECEPTOR TURNOVER

Research Project

Project/Area Number 09671073
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionJIKEI UNIVERSITY SCHOOL OF MEDICINE

Principal Investigator

OHKAWA Kiyoshi  JIKEI UNIVERSITY SCHOOL OF MEDICINE,DEPARTMENT OF BIOCHEMISTRY,PROFESSOR, 医学部, 教授 (90112812)

Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1998: ¥400,000 (Direct Cost: ¥400,000)
KeywordsEGF-receptor / glycation / ubiquitination / diabetes / 上皮増殖因子 / 上皮増殖因子リセプター / ユビキチン / グリケーション / 発癌
Research Abstract

An epidermal growth factor receptor (EGFR) highly expressing human squamous cell carcinoma cell line, A431. which was cultured with a medium containing 20g/L of glucosefor adaptation of the cells to high glucose condition, showed moderate growth retardation (doubling time, 49h) as compared with that with normo-concentration of glucose (doubling time, 33h). A431 cultured with high glucose condition (HC) contained relatively elevated concentration of two forms of ubiquitin (multiubiquitin chain, MU, 100ng/mg protein and free ubiquitin, FU, 250ng/mg protein), which was almost similar to that in original A431 cells (NC). When HC was cultured at 4゚C, EGFR concentration determined with ELISA was 124U, which was approximately equal level to that In NC (115U). Under the conventional culture conditions at 37゚C, EGFR concentration in NC slightdccreased. By contrast, the receptor concentration in HC decreased extremely up to half level at 4゚C culture because of enhanced metabolism and down regula … More tion of EGFR.Immunoprecipitated EGFR in HC reacted with an antibody against advanced glycation endoproduct, but not in NC.By incubation of cells with EGF, increased levels of ubiquitinated EGFR were detectable clearly using an ELISA specific to ubiquitinated EGFR as well as a procedure of EGFR-immunoprecipitation followed by western blot by an anti-ubiquitin antibody. By western blot analysis, EGF-stimulated EGFR phosphorylation was also reduced in intensity in HC compared to in NC.These results indicated that the hyperglucose condition, such as diabetic condition, might induce the unusual down regulation of the EGFR with structural abnormality in the molecule. These results also suggested that some signal transduction pathways, namely via receptor type tyrosine phosphorylation mechanism. might be obstructed under such environment. To determine the effect on expression of EGFR-mRNA and whether presence or absence of site directed glycation of EGFR under the high glucose environment will be necessary to elucidate the diabetic status and cancer incidence. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Ohkawa, K.: "Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells." Anti-cancer drugs. 8. 199-203 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Serum concentrations of free ubiquitin and multiubiquitn chains." Clin.Chem.43. 1188-1195 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferrase activity ; comparison between doxorubichin-sensitive and -resistant rat hepatoma cells." Br.J.Cancer. 76. 1333-1337 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Proteasome inhibitors which induce neurite outgrowth from PB12h cells cause different subcellular accumulations of multi-ubiquitin chains." Neurochem. Res.23. 1435-1443 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Drug conjugate of doxorubicine with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells." Anti-cancer drugs. 8. 199-203 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Serum concentrations of freen ubiqutin and multiubiquitin chains." Clin.Chem.43. 1188-1195 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression of glutathione S-transferase activity ; comparison between doxorubicine-sensitive and -resistant rat hepatoma cells." Br.J.Cancer. 76. 1333-1337 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa, K.: "Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiqutin chains." Neurochem.Res.23. 1435-1443 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Ohkawa,K.: "Drug conjugate of doxorubisin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells." Anti-cancer drugs. 8. 199-203 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohkawa,K.: "Serum concentrations of free ubiquitin and multiubiquitin chains." Clin.Chem.43. 1188-1195 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohkawa,K.: "Glutathione-doxorubicin conjugate expresses potent cytotoxicity by suppression or glutathione S-transferase activity;comparison between doxorubicin-sensitive and -resistant rat hepatoma cells." Br.J.Cancer. 76. 1333-1337 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Ohkawa,K.: "Proteasome inhibitors which induce neurite outgrowth from PC12h cells cause different subcellular accumulations of multi-ubiquitin chains." Neurochem Res.23. 1435-1443 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Asakura,T.: "Drug conjugate of doxorubicin with glutathione is a potent reverser of multi-drug resistance in rat hepatoma cells." Anti-cancer drugs. 8. 199-203 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Takada,K.: "Serum concentrations of free ubiquitin and multiubiquitin chains." Clin.Chem.43. 1188-1195 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi